To the best of our knowledge, this is the first report using a meta-analysis of 715 data sets (86, 733 samples) identifying BRF2 as overexpressed in 60% of breast cancer data sets in an Outlier analysis. The gene discussed is BRF2; the disease is breast carcinoma.